INTERNATIONAL PATENT: MYONGJI MEDICAL FOUNDATION, 의료법인 명지의료재단 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LUNG PAPILLARY ADENOCARCINOMA COMPRISING K-RAS-SPECIFIC ACTIVATED T CELLS AND METHOD FOR PREPARING SAME"

GENEVA, Feb. 23 -- MYONGJI MEDICAL FOUNDATION (55, Hwasu-ro 14beon-gilDeogyang-gu, Goyang-siGyeonggi-do 10475), 의료법인 명지의료재단 (경기도고양시 덕양구화수로14번길 55) filed a patent application (PCT/KR2024/021435) for "PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LUNG PAPILLARY ADENOCARCINOMA COMPRISING K-RAS-SPECIFIC ACTIVATED T CELLS, AND METHOD FOR PREPARING SAME" on Dec 30, 2024. With publication no. WO/2026/038623, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classificatio...